Protagonist Therapeutics Inc (PTGX) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States.
Total Assets Chart for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc (PTGX) total assets for FY2025 were USD 669.9M, a -10.0% change from FY2024. Protagonist Therapeutics Inc's total assets grew from USD 10.3M in 2014 to USD 669.9M in 2025 (6386.2% over 11 years). Total assets compound annual growth rate: 5-year CAGR of 15.6%, 10-year CAGR of 46.4%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $8.96B
- Implied Share Price
- $138.43
- Enterprise Value
- $8.47B
- Revenue (TTM)
- $281.99M
- EBITDA
- $59.88M
- Profit Margin
- 29.40%
- Trailing P/E
- 134.40
- Forward P/E
- 36.90
- Price/Book (MRQ)
- 11.00
- Price/Sales (TTM)
- 31.77
- EV/EBITDA
- 141.64
- EV/Revenue
- 30.08
- Dividend Yield
- —
- Book Value
- $13.01
- Free Cash Flow (FY2025)
- $56.08M
- Free Cash Flow Yield
- 0.63%
Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.